Assessment for Implementation Methods in Sepsis
Launched by RHODE ISLAND HOSPITAL · Aug 4, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Assessment for Implementation Methods in Sepsis," is looking at how different treatment approaches for sepsis (a serious infection) can help improve patient outcomes. Specifically, it compares two treatment plans: one that focuses on starting treatment within one hour of diagnosis and another that allows for treatment to start within three hours. The goal is to see which approach leads to better survival rates and fewer complications, like respiratory failure, for patients who come to the emergency department with sepsis. The trial will also analyze patient data to identify specific groups of patients that may respond better to certain treatments.
To participate in this trial, you must be an adult aged 18 or older and meet specific criteria indicating that you are experiencing sepsis within six hours of arriving at the emergency room. Certain patients, such as those who are pregnant, transferred from another hospital, or those receiving comfort care, are not eligible. If you choose to participate, you will receive one of the two treatment plans being studied, and your progress will be monitored closely to gather important information about the effectiveness of these approaches. This trial is currently recruiting participants, and your involvement could help shape future treatments for sepsis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults \>=18
- • Patient meets criteria for time zero (sepsis within 6 hours of ED triage and the 3 criteria-infection, 2 SIRS and 1 or more organ dysfunctions, must be met within 3 hours of each other.
- Exclusion Criteria:
- • Last admission for patients admitted to same hospital once
- • Pregnant women
- • All transfers from another hospital
- • Individuals who are made comfort care only within 6 hours of admission to ED
- • Moribund patients
About Rhode Island Hospital
Rhode Island Hospital, a leading academic medical center and a key component of the Lifespan health system, is committed to advancing medical research and improving patient care through innovative clinical trials. As a principal teaching hospital for The Warren Alpert Medical School of Brown University, it integrates cutting-edge research with high-quality clinical services. The hospital's extensive clinical trial program spans various fields, including oncology, cardiology, neurology, and more, aiming to enhance treatment options and patient outcomes. By fostering collaboration among researchers, clinicians, and patients, Rhode Island Hospital plays a pivotal role in translating scientific discoveries into effective therapies and improving healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Patients applied
Trial Officials
Mitchell Levy, MD
Principal Investigator
Rhode Island Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials